Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
复制标题
DOI:
10.1002/hep.22519
复制
发表时间:
2008-11
期刊:
影响因子:
13.5
通讯作者:
Huang, Wendong
中科院分区:
文献类型:
--
作者:
Wang, Yan-Dong;Chen, Wei-Dong;Wang, Meihua;Yu, Donna;Forman, Barry M.;Huang, Wendong
The farnesoid X receptor (FXR) is a nuclear receptor that plays key roles in hepatoprotection by maintaining the homeostasis of liver metabolism. FXR null mice display strong hepatic inflammation and develop spontaneous liver tumors. In this report, we demonstrate that FXR is a negative modulator of NF-κB-mediated hepatic inflammation. Activation of FXR by its agonist ligands inhibited the expression of inflammatory mediators in response to the NF-κB activation in both HepG2 cells and primary hepatocytes cultured in vitro. In vivo, compared to the wild-type controls, FXR−/−mice displayed elevated mRNA levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interferon-γ-inducible protein 10 (IP-10), and interferon-γ (IFN-γ) in response to lipopolysacchride (LPS). Examination of FXR−/− livers showed massive necroses and inflammation after treatment with LPS at a dose that does not induce significant liver damage and inflammation in wild-type mice. Moreover, transfection of a constitutively active FXR expression construct repressed the iNOS, COX-2, IP-10 and IFN-γ mRNA levels induced by LPS administration. FXR activation had no negative effects on NF-κB-activated anti-apoptotic genes, suggesting that FXR selectively inhibits the NF-κB-mediated hepatic inflammatory response but maintains or even enhances the cell survival response. On the other hand, NF-κB activation suppressed FXR-mediated gene expression both in vitro and in vivo, indicating a negative crosstalk between the FXR and NF-κB signaling pathways. Our findings reveal that FXR is a negative mediator of hepatic inflammation, which may contribute to the critical roles of FXR in hepatoprotection and suppression of hepatocarcinogenesis.
登录
查看更多内容
影响因子:
64.8
作者:
Pascual, G;Fong, AL;Glass, CK
通讯作者:
Glass, CK
影响因子:
16
作者:
Ghisletti, Serena;Huang, Wendy;Glass, Christopher K.
通讯作者:
Glass, Christopher K.
影响因子:
8
作者:
Baek, JH;Jang, JE;Kim, KW
通讯作者:
Kim, KW
影响因子:
4.8
作者:
Najima, Y;Yahagi, N;Shimano, H
通讯作者:
Shimano, H
影响因子:
56.9
作者:
Huang, WD;Ma, K;Moore, DD
通讯作者:
Moore, DD